Objective To explore the efficacy and safety of ibuprofen in patent ductus arteriosus (PDA) treatment in premature infants, and investigate correlation factors that effected the efficacy. Methods 53 cases of PDA that matched the selected standards were treated with ibuprofen orally. The closure of ductus arteriosus and adverse reactions were under observation. Results Effective power of first treatment in our research was 84. 91% ,8 cases failed. Two cases of PDA were closed after the second course of treatment. The total effective rate was 88.68%. This research also indicated that the time to use ibuprofen and the birth weight of children were of positive and notable effect on closure rate of PDA. No serious adverse reaction occurred during the research. Conclusion Ibuprofen in PDA treatment is safe and of certain efficacy. It can obviously elevate the rate of PDA closure in premature infants to use ibuprofen early.
Key words:
Patent ductus arteriosus; Ibuprofen; Premature infant